Nerve Blocks vs Local Injections for Post-op Pain Prevention in Laparoscopic Cholecystectomy in Children
Transversus Abdominis Plane Block vs. Local Wound Infiltration for Elective Laparoscopic Cholecystectomy in Children and Adolescents: A Prospective Randomized-Controlled Trial
1 other identifier
interventional
87
1 country
1
Brief Summary
The objective of this study is to compare transversus abdominis plane (TAP) blocks to local wound infiltration (LWI) in terms of postoperative pain control in pediatric patients undergoing elective laparoscopic cholecystectomy. Our hypothesis is that TAP blocks will be superior to LWI for postoperative pain control resulting in decreased use of opioid / narcotic pain medication and decreased pain scored in the immediate 24-hour postoperative period. The rationale is that determining the effect of analgesia in this pediatric population is important to optimize clinical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 25, 2016
CompletedStudy Start
First participant enrolled
January 6, 2017
CompletedFirst Posted
Study publicly available on registry
January 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedMarch 3, 2023
March 1, 2023
5.7 years
November 25, 2016
March 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Amount of narcotic pain medication
24 hours post-op
Time to first request of pain medication
From post-anesthesia care unit "(PACU) in" time to first pain medication dose, up to 24 hours
Study Arms (2)
TAP blocks
ACTIVE COMPARATORTAP block group will receive three injections performed by an Anesthesiologist trained in the procedure, prior to initiation of the surgical procedure. Bilateral posterior transversalis fascial plane blocks and a right sided subcostal transverse abdominal plane block will be placed under ultrasound guidance. Normal saline will be used to confirm proper muscle layer placement before instillation of the local anesthesia. All patients will receive 2.5 mg/kg or 1 mL/kg of 0.2% ropivacaine with maximum of 60 mL (divided equally amongst the injection sites).
Local Wound Infiltration
ACTIVE COMPARATORLocal wound infiltration (LWI) will be performed by the operative surgeon using 2.5 mg/kg or 1 mL/kg of 0.2% ropivacaine with maximum of 60 mL divided amongst the four port sites. 40% of the total dose will be given at the umbilicus, and 20% will be given at each of the other 3 ports. The majority of the anesthetic will be administered at the peritoneal level. Laparoscopic/robotic cholecystectomy will be performed with a port at the umbilicus and three smaller ports in a standard fashion in the subxiphoid and right upper quadrant regions. If conversion to open cholecystectomy occurs, the study data will still be collected, but the patient's data will be excluded from analysis.
Interventions
ultrasound guided transversus abdominis plane block utilizing 2.5 mg/kg or 1 mL/kg of 0.2% ropivacaine
local anesthesia provided at the surgical site utilizing 2.5 mg/kg or 1 mL/kg of 0.2% ropivacaine
Eligibility Criteria
You may qualify if:
- yrs of age at date of enrollment.
- Elective laparoscopic or da Vinci cholecystectomy scheduled for any diagnostic reason.
You may not qualify if:
- Chronic pain or chronic use of narcotic or other prescription pain medications.
- Use of pain medication within 24 hours before surgery
- Prior major abdominal surgery
- Evidence of acute inflammation
- Patients with acute cholecystitis
- Bleeding / coagulation disorder
- Seizure disorder
- Renal dysfunction
- Infection at injection sites for TAP block or trocar placement
- Contraindication to LWI or TAP block procedure, as determined by surgeon or anesthesiologist performing the procedure (including, but not limited to, previous incision distorting anatomy or inability to visualize anatomical planes)
- Any known allergy to medications used in this study
- Patient unable to verbalize pain score or independently assess pain level
- Unstable patient in need of emergent intervention at surgeon discretion
- Patients who are known to be pregnant
- Patients who are currently prisoners
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Riley Hospital for Children at IU Health
Indianapolis, Indiana, 46202, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gray Brian, MD
Indiana University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Pediatric surgeon
Study Record Dates
First Submitted
November 25, 2016
First Posted
January 16, 2017
Study Start
January 6, 2017
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
March 3, 2023
Record last verified: 2023-03